ArticleClinical epigenetics2022

Chidamide and venetoclax synergistically exert cytotoxicity on multiple myeloma by upregulating BIM expression.

Liqin Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.